Circadian Adaptive DBS in Essential Tremor
NCT: NCT06635811 · RECRUITING
Brief Summary
Deep brain stimulation (DBS) of the thalamus is an effective treatment for medically refractory essential tremor (ET). DBS involves delivering continuous stimulation to the brain through electrodes permanently implanted in the thalamus. Despite proven effectiveness, the long-term benefit of DBS can wane over time (habituation) and side effects, including paresthesia and dysarthria, often limit the amplitude of the stimulation, resulting in suboptimal control of tremor. In clinical practice, many groups advise patients to switch their devices off at night to avoid habituation and reduce side effects. However, manually turning off the device at night can result in uncontrolled tremor when the patient moves at night. This study aims to develop an algorithm that automatically turns off stimulation when a patient is asleep, based on circadian brain signals. Turning off stimulation could potentially improve the therapy by limiting adverse effects, increasing efficacy, reducing the risk of habituation, and prolonging battery life. This study will evaluate the feasibility, safety, and tolerability of circadian adaptive DBS.
Frequently Asked Questions
What is Circadian Adaptive DBS in Essential Tremor?
Circadian Adaptive DBS in Essential Tremor is a clinical trial registered under NCT06635811. Current status: RECRUITING.
What is the status of NCT06635811?
The current status of NCT06635811 (Circadian Adaptive DBS in Essential Tremor) is: RECRUITING.
When did Circadian Adaptive DBS in Essential Tremor start?
Circadian Adaptive DBS in Essential Tremor started on 2025-05-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.